Evidence map›Paper›PMID 40672617›Full record

ArticleAmerican journal of translational research2025

Venous thrombolysis combined with Tirofiban in the treatment of capsular warning syndrome: a case report.

Qingqing Wang, Huihui Wang, Hongjing Wang, Shaoying Wang, Dan Xing, Yizhe Meng

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qingqing WangDepartment of Neurology, The Eighth People's Hospital of Hebei Province Shijiazhuang 050000, Hebei, China.
Huihui WangDepartment of Rehabilitation Medicine, The First Hospital of Hebei Medical University Shijiazhuang 050023, Hebei, China.
Hongjing WangOperation Room, The Affiliated Hospital of Qingdao University Qingdao 266000, Shandong, China.
Shaoying WangDepartment of Neurology, The Eighth People's Hospital of Hebei Province Shijiazhuang 050000, Hebei, China.
Dan XingDepartment of Medical Examination, The Eighth People's Hospital of Hebei Province Shijiazhuang 050000, Hebei, China.
Yizhe MengDepartment of Neurology, Hebei Chest Hospital Shijiazhuang 050041, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capsular warning syndrome (CWS) is a subtype of transient ischemic attack (TIA), accounting for 4.5% of all TIAs. Due to the absence of cortical signs within 24 hours of onset, CWS is often misdiagnosis or overlooked, making it a rare clinical syndrome with a high disability rate and an increased risk of progressing to cerebral infarction. Clinical practitioners need to pay close attention and provide proactive and effective treatment. Currently, there is no universally recognized treatment standard. This report presents the experience of treating a CWS patient at our hospital with venous thrombolysis combined with Tirofiban.

Indexed as

Capsular warning syndromeTirofibanvenous thrombolysis

Identifiers

PMID40672617
PMCPMC12261156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.